Malignant mesothelioma

60Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Mesothelioma is a malignant tumour of the pleura or peritoneum caused by asbestos. It is increasing in frequency and the prognosis remains grim, with average survival around 1 year. Sources of data: Medical literature and personal experience. Areas of agreement: Amphibole fibres are far more potent than chrysotile in causing mesothelioma. Areas of controversy: A minority view suggests that mesotheliomas in those exposed to chrysotile are caused only by tremolite (an amphibole) which contaminates chrysotile. There is a hypothesis, for which evidence is weakening, that Simian virus 40 may cause mesothelioma. Growing points: There is emerging evidence of genetic variation in susceptibility to fibre carcinogenesis. There are developments in treatment, particularly chemotherapy with pemetrexed and cisplatin which prolongs survival and helps symptoms. Areas timely for developing research: Targeted agents for treatment are under investigation and may improve the outlook. The role of radical and palliative surgery requires clarification. © The Author 2010. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Rudd, R. M. (2010, March). Malignant mesothelioma. British Medical Bulletin. https://doi.org/10.1093/bmb/ldp047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free